Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

923.71 -11.31 (-1.21%)
Official Closing Price Updated: 7:00 PM EDT, Sep 13, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,045,356
Open 937.01
Bid (Size) 923.06 (1)
Ask (Size) 926.50 (1)
Prev. Close 935.02
Today's Range 922.10 - 942.35
52wk Range 516.57 - 972.53
Shares Outstanding N/A
Dividend Yield 0.49%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Stocks to Buy and Hold Forever
These stocks are built for the long run. 
Via The Motley Fool
Time To Invest And Or Trade In Bio-Tech Stocks?
Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help... 
Via Talk Markets
Topics ETFs

Performance

YTD
+55.98%
+55.98%
1 Month
-0.86%
-0.86%
3 Month
+5.15%
+5.15%
6 Month
+22.48%
+22.48%
1 Year
+56.13%
+56.13%

More News

Read More
Stock Market Rally Revives; Apple iPhone 16, Nvidia, Oracle, Adobe In Focus: Weekly Review
Via Investor's Business Daily
6 Incredible Reasons to Invest in Eli Lilly
Via The Motley Fool
Looking At Eli Lilly's Recent Unusual Options Activity
Via Benzinga
Unpacking the Latest Options Trading Trends in Eli Lilly
Via Benzinga
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 20 Years
Via Benzinga
A Glimpse Into The Expert Outlook On Eli Lilly Through 28 Analysts
Via Benzinga
Eli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound
Via Benzinga
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now
Via The Motley Fool
3 No-Brainer Biotech Stocks to Buy With $200 Right Now
Via The Motley Fool
Why Roche Holdings Stock Withered on Wednesday
Via The Motley Fool
Why Viking Therapeutics Stock Rocked the Market Today
Via The Motley Fool
Smart Money Is Betting Big In LLY Options
Via Benzinga
Harvest ETFs (TSX: LLYH, LLYH.U, AMZH, AMZH.U, MSFH, MSFH.U, NVDH, NVDH.U, LLHE, LLHE.U, AMHE, AMHE.U, MSHE, MSHE.U, NVHE, NVHE.U ) Closes the Market
Via Newsfile
Topics ETFs
4 No-Brainer Stock Splits to Buy Now
Via The Motley Fool
Could Elon Musk Become The World's First Trillionaire? Tesla's Success Could Make It Happen As Early As...
Via Benzinga
Novo Nordisk Jumps After New Weight-Loss Pill Tops Wegovy; Eli Lilly, Viking Shares Rise
Via Investor's Business Daily
Ozempic Maker Novo Nordisk Touts Encouraging Data From New Obesity Pill Showing Double Weight Loss Compared To Wegovy
Via Benzinga
Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound)
Via The Motley Fool
Is Hims & Hers Health the Next Teladoc?
Via The Motley Fool
Exposures COVID-19
Prediction: These 2 Companies Will Split Their Stocks by 2027
Via The Motley Fool
Novo Nordisk Reports Positive Results Of Weight-Loss Drug Liraglutide For Children As Young As 6, Eyes FDA And EMA Approval
Via Benzinga
Exposures Product Safety
Invest While You Can: Pullbacks on These 3 Stocks Won’t Last Long
Via MarketBeat
Topics Economy
Exposures Economy Interest Rates
Zepbound And Mounjaro Maker Eli Illy Has A New CFO As It Navigates Regulatory Challenges: What You Should Know
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.